Cite
A multi-cancer analysis unveils ITGBL1 as a cancer prognostic molecule and a novel immunotherapy target.
MLA
Wu, Ziyu, et al. “A Multi-Cancer Analysis Unveils ITGBL1 as a Cancer Prognostic Molecule and a Novel Immunotherapy Target.” Oncologie (De Gruyter), vol. 26, no. 2, Mar. 2024, pp. 195–210. EBSCOhost, https://doi.org/10.1515/oncologie-2023-0455.
APA
Wu, Z., Liu, Z., Gu, C., Wu, Y., Li, Y., Zhou, Z., & Yang, X. (2024). A multi-cancer analysis unveils ITGBL1 as a cancer prognostic molecule and a novel immunotherapy target. Oncologie (De Gruyter), 26(2), 195–210. https://doi.org/10.1515/oncologie-2023-0455
Chicago
Wu, Ziyu, Zhihong Liu, Changji Gu, Yong Wu, Yanan Li, Zeyang Zhou, and Xiaodong Yang. 2024. “A Multi-Cancer Analysis Unveils ITGBL1 as a Cancer Prognostic Molecule and a Novel Immunotherapy Target.” Oncologie (De Gruyter) 26 (2): 195–210. doi:10.1515/oncologie-2023-0455.